ESMO 2024: Optimising the personalisation of prostate cancer treatment
Prof Eggermont hosts a press conference at ESMO 2014 about the Cancer Core Europe initiative, which looks to collate data and research from six key European cancer centres to create a fully integrated and collaborative 'e-hospital'.
Here, Prof Ringborg gives an overview of the Netherlands Cancer Institute and its place within the Cancer Core Europe initiative.
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Hormonal receptor positive breast cancer adjuvant and metastatic indications
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in radiology Tanzania
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer